Pulmonx Corp (LUNG) stock
LUNGNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 7/3044% below fair value
$2.73−0.06 (-2.32%)
Close on Nov 17, 2026Market cap $117.46MP/E –Yield –
Pulmonx market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Pulmonx's market cap was $127.99M on Nov 11, 2026, against $66.82M a year earlier. Over the last 5 years it ranged from $53.34M to $1.18B, with a median of $293.11M.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $127.99M | +40.4% |
| 2025 | Dec 31, 2025 | $91.15M | -66.0% |
| 2024 | Dec 31, 2024 | $268.12M | -45.1% |
| 2023 | Dec 29, 2023 | $488.34M | +54.9% |
| 2022 | Dec 30, 2022 | $315.35M | -73.3% |
| 2021 | Dec 31, 2021 | $1.18B | +350.0% |
| 2020 | Dec 31, 2020 | $262.40M | – |
See a number that looks wrong?